Gensight Biologics SA

11/20/2023 | Press release | Distributed by Public on 11/20/2023 11:11

GenSight Biologics announces launch of an offering for an indicative amount of €5 million that has received subscription commitments from new and existing shareholders totaling[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.